Alcon Laboratories, Inc.
6201 South Freeway
Fort Worth
Texas
76134
United States
Tel: 800-451-3937-or-817-293-0450
Fax: 817-551-4615
Website: http://www.alconinc.com/
115 articles about Alcon Laboratories, Inc.
-
Novartis Corporation (JOBS) Seeks to Buy Rest of Alcon Laboratories, Inc. for $39 Billion
1/4/2010
-
Alcon Laboratories, Inc. Posts 5.9 Percent Sales Growth for Third Quarter
10/28/2009
-
Potentia Pharmaceuticals, Inc. Enters into Licensing and Purchase Option Agreements with Alcon Laboratories, Inc.; Deal Provides Path for Alcon to Acquire Potentia
10/23/2009
-
Synergetics USA, Inc. Announces Stay of Alcon Research, Ltd. Patent and Trademark Infringement Lawsuit
9/25/2009
-
Alcon Laboratories, Inc. to Acquire Swiss Biotechnology Firm, ESBATech for $589 Million
9/14/2009
-
Alcon Laboratories, Inc. Discontinues Development of Anecortave Acetate for Intraocular Pressure Reduction
7/6/2009
-
Alcon Laboratories, Inc. Achieves Required Ownership in WaveLight to Initiate Squeeze-out
5/13/2009
-
Alcon Research Institute Awards Six Top Scientists with Unrestricted Grants for Research on Eye Disease
4/16/2009
-
Alcon Laboratories, Inc. Signs Contract with LCA-Vision for 75 ALLEGRETTO WAVE(R) Excimer Lasers
3/10/2009
-
Alcon Laboratories, Inc. Names Insider Kevin Buehler as New CEO
1/9/2009
-
Origenis Broadens Research Alliance with Alcon Research, Ltd. to Develop Novel Ophthalmic Compounds
10/23/2008
-
Alcon Laboratories, Inc. Expands Licensing Agreement with GlaxoSmithKline
10/15/2008
-
Alcon Research Institute Recognizes Seven Top Researchers in Ophthalmology with Unrestricted Grants
8/22/2008
-
Alcon Laboratories, Inc. Ends Macular Degeneration Drug Program
7/14/2008
-
Novartis AG Completes Acquisition of 25% stake in Alcon Laboratories, Inc. from Nestlé, First Step Toward Majority Ownership of the World Leader in Eye Care
7/8/2008
-
Alcon Laboratories, Inc. Announces Plans to Build Pharmaceutical Manufacturing Plant in Singapore
4/14/2008
-
Novartis Corporation to buy Nestle's Alcon Laboratories, Inc. Stakes for $39B
4/7/2008
-
Alcon Announces Fourth Quarter 2007 Financial Release and Conference Call Dates
1/10/2008
-
Lantibio Inc. and TRB Chemedica Announce Licensing Agreement with Alcon Laboratories, Inc. for US Development and Marketing of Dry Eye Drug
11/6/2007
-
FDA Wants Another Study to OK Alcon Laboratories, Inc. Eye Disease Drug
9/25/2007